Anaphylaxis and Medical Emergencies in the Clinic: Being Ready

July 26, 2026

Key points

Anaphylaxis is defined by systemic involvement: sudden, rapidly progressing problems with airway, breathing or circulation, usually alongside skin changes.
A localised allergic reaction, such as swelling or hives confined to the injection site, is not anaphylaxis unless those systemic signs appear, and it is managed differently.
Hyaluronidase is a useful real-world example: local hypersensitivity reactions are relatively uncommon, and true anaphylaxis from it is rarer still.
Patients with a wasp or bee sting allergy carry a specific, easily-missed increased risk with hyaluronidase, and this is recognised by ACE Group World as a relative contra-indication.

One of the most common fears among newer practitioners is not knowing whether what they are looking at is a genuine emergency or something that looks frightening but is not. Nowhere is that truer than with allergic-type reactions. A patient can develop swelling, redness or hives during or after a treatment, and the instinct is to assume the worst. Sometimes that instinct is correct. Often, it is a localised reaction that, while it needs your full attention, is not anaphylaxis and does not need the same response. Knowing the difference, calmly and in advance, is what this guide is about.

This guide is written for anyone delivering aesthetic treatments in the UK, whether you come from a medical background as a nurse, doctor, dentist or prescriber, or from a non-medical route such as beauty therapy. Recognising the difference between anaphylaxis and a non-anaphylactic allergic reaction is not a skill reserved for one professional group. Everyone in the treatment room should be able to tell the two apart, because the correct response depends on it.

A note before we go further. This is preparedness and governance guidance, not clinical instruction. It does not tell you how to diagnose or treat a specific patient, and it is not a substitute for hands-on anaphylaxis and complications training, which should be refreshed at least annually. What follows is about understanding the distinction that recognised UK guidance draws between these two presentations, so that your protocol and your escalation decisions are built on an accurate foundation. Always act within your scope of practice, training, competence and indemnity, and follow recognised clinical guidance such as that of the Resuscitation Council UK and the ACE Group World.

What actually makes something anaphylaxis

It is tempting to think of anaphylaxis as simply “a severe allergic reaction,” but that is not quite how UK resuscitation guidance defines it, and the distinction matters in practice. Anaphylaxis is identified by sudden onset and rapid progression of symptoms affecting the airway, breathing or circulation, usually alongside skin or mucosal changes such as flushing, hives or swelling. It is the airway, breathing or circulation involvement that does the defining work. Skin changes alone, however alarming they look, are not sufficient on their own, and gastrointestinal symptoms such as nausea or abdominal pain, in the absence of airway, breathing or circulation problems, are not usually considered anaphylaxis either.

This is precisely why swelling or hives confined to the treatment area can be so unsettling to witness and yet not meet the threshold for anaphylaxis. A patient with a red, swollen, itchy area around an injection site, who is breathing normally, talking normally and has a stable pulse, is having a localised allergic reaction. The same patient developing throat tightness, difficulty breathing, wheeze, a sense of the throat closing, dizziness or a rapid drop in how they are presenting has crossed into anaphylaxis, and that changes everything about how you respond. Any doubt should be resolved in favour of treating it as the more serious event. The point of understanding the distinction is not to talk yourself out of calling for help, but to make sure your response is genuinely proportionate and not guesswork.

Why hyaluronidase is such a useful example

Hyaluronidase, used to dissolve dermal filler, illustrates this distinction well because it produces a genuine spectrum of reactions, most of which are not anaphylaxis. ACE Group World’s published guidance on the use of hyaluronidase in aesthetic practice describes localised hypersensitivity, soft tissue swelling, itching and redness at the injection site occurring at a rate of roughly 0.05 to 0.69 per cent, with urticaria or angioedema reported in under 0.1 per cent of cases. True anaphylaxis from hyaluronidase is considerably rarer still, and has mainly been associated with high doses or intravenous administration rather than the doses and routes used in aesthetic practice.

There is one specific, easily-missed risk factor worth building into every consultation involving hyaluronidase. ACE Group World identifies a history of allergic reaction to wasp or bee stings as a relative contra-indication, because the venom of stinging insects can itself contain hyaluronidase, and this appears to be a genuine mechanism of sensitisation in affected individuals. A general history of allergies is not, on its own, thought to be relevant, but a specific history of reacting to a wasp or bee sting is exactly the kind of detail that belongs in a proper allergy and medical history, asked about before hyaluronidase is used rather than after a reaction has started.

Two further practical points come from the same guidance and are worth building into your own protocol rather than treated as optional extras. First, an intradermal patch test before elective use of hyaluronidase is recommended as a way of identifying a reaction risk in advance, with the exception of a genuine vascular occlusion, where the urgency of treatment outweighs the value of waiting for a test result. Second, whatever the indication, ACE Group World recommends keeping the patient under clinical observation for around 60 minutes after hyaluronidase is administered, since most reactions, including delayed ones, tend to declare themselves within that window rather than immediately.

Why the response has to differ

A localised allergic reaction and true anaphylaxis are not different severities of the same event that you manage the same way, just more urgently. UK resuscitation guidance is specific that the emergency, life-saving response, including immediate adrenaline, is for anaphylaxis, defined by that airway, breathing or circulation involvement. A localised reaction confined to skin, without those systemic signs, is generally managed with a calmer, watchful approach: symptomatic relief, close and continued observation, and a clear, pre-agreed threshold at which you would reclassify the situation and move straight to your anaphylaxis protocol if anything changes.

This is where a written protocol earns its keep. It should tell you, and everyone else present, what specifically to watch for that would tip a reaction from localised into systemic, who is responsible for monitoring the patient continuously while that watching period continues, and exactly what triggers an immediate escalation rather than a “wait and see” approach. The goal is a practitioner who is neither trigger-happy nor complacent, but who is working from a clear, pre-agreed decision point rather than a gut feeling made under pressure.

After the event: observation and referral

Current NICE guidance on anaphylaxis assessment and referral (NG258, which replaced the earlier CG134) is clear that anyone who has had emergency treatment for suspected anaphylaxis should be observed for a period afterwards, because reactions can recur, and should be referred to a specialist allergy service for proper assessment and investigation rather than the incident simply being closed once the immediate danger has passed. This matters for aesthetic practice too. If you have managed, or been part of managing, a suspected anaphylactic reaction, your responsibility does not end when the patient stabilises. Arranging emergency conveyance to hospital, and ensuring the patient is aware of the importance of specialist allergy follow-up, are part of doing this properly, not optional extras.

Even for a reaction you have assessed as localised rather than anaphylactic, continued observation for a sensible period and clear safety-netting advice to the patient, telling them exactly what to watch for and when to seek urgent help after they leave, is good practice and part of a defensible record.

Documentation

Whichever type of reaction you manage, contemporaneous documentation is essential: what you observed, in what order, what action you took, the time of every key decision, and how the patient responded. This is what allows you, your indemnity provider and, if it is ever needed, a regulator to see that your assessment and response were reasoned and appropriate, not guesswork after the fact.

The bottom line

Learning to tell a localised allergic reaction from true anaphylaxis is not about downplaying risk. It is about responding accurately rather than reflexively, so that patients who need immediate emergency treatment get it without delay, and patients having a milder reaction are not needlessly escalated in a way that itself increases anxiety and risk. That accuracy comes from understanding the criteria properly, building them into your protocol, and knowing your own escalation threshold before you ever need it.

Our Emergency Preparedness Bundle and Clinical Emergency Flowcharts bring this kind of decision-making together in a form you can keep in your treatment space, and our Am I Emergency Ready? self-audit checklist is a free way to see where your own preparedness might have gaps. Read alongside our beginner’s guide to clinical governance, they help you build genuine, documented readiness rather than hoping you will simply know what to do in the moment.

Frequently asked questions

Is swelling after hyaluronidase always a sign of anaphylaxis? No. Localised swelling, itching or redness confined to the injection site is a recognised, relatively uncommon hypersensitivity reaction to hyaluronidase, and is not the same as anaphylaxis. Anaphylaxis requires airway, breathing or circulation involvement, which is a different and more serious presentation.

Why does a wasp or bee sting allergy matter for hyaluronidase? ACE Group World identifies a history of allergic reaction to wasp or bee stings as a relative contra-indication to hyaluronidase, because insect venom can itself contain hyaluronidase, which appears to be a genuine mechanism of sensitisation. This is worth asking about specifically during consultation, before hyaluronidase is used.

Should patients be patch tested or observed after hyaluronidase? ACE Group World guidance recommends an intradermal patch test before elective use of hyaluronidase, except in a genuine vascular occlusion where the urgency of treatment takes priority, plus around 60 minutes of clinical observation after administration, since most reactions, including delayed ones, tend to appear within that window.

What should happen after any suspected anaphylactic reaction? Current NICE guidance (NG258) recommends a period of observation and referral to a specialist allergy service for proper assessment, rather than treating the incident as closed once the patient has stabilised.

Does this article tell me how to treat anaphylaxis? No. This is preparedness and governance guidance, not clinical instruction. Managing anaphylaxis and allergic reactions requires hands-on training refreshed at least annually, and must follow your own clinic protocol and recognised clinical guidance such as that of the Resuscitation Council UK, within your scope, competence and indemnity.

This article is preparedness and best-practice guidance for UK aesthetic practitioners. It is not clinical instruction and does not describe how to diagnose or treat a specific medical emergency. Always act within your scope of practice, training, competence and indemnity, follow your own clinic protocol and recognised clinical guidance such as that of the Resuscitation Council UK and the ACE Group World, and undertake appropriate face-to-face anaphylaxis and complications training. In a genuine emergency, call 999 without delay.